Ghana Health Nest

  • News
  • Public Health
  • Big Pharma
  • Discover
  • Lifestyle
  • Multimedia
Reading: Ghana spends USD 126,415,269 on HIV interventions in 2022
Support

Ghana Health Nest

Support
Search
  • News
  • Public Health
  • Big Pharma
  • Discover
  • Lifestyle
  • Multimedia
©2024 Vessel Media. All Rights Reserved.

Ghana spends USD 126,415,269 on HIV interventions in 2022

The main beneficiary population was Person Living with HIV who received the highest proportion of funds thus 54 per cent on the total expenditure, followed by the general population, 6.2 per cent and 3.5 per cent for key populations.

Linda Aryeetey
By Linda Aryeetey Published August 23, 2024
Share
3 Min Read
Highlights
  • The spendings as compared to USD 127,828,300 in 2021, a one per cent decrease in total expenditure in 2022.
  • The assessment showed that international organisations, primarily the global fund and the US government accounted for the treatment of the largest portion of financing

Accra, Aug. 23 – Ghana in 2022, spent USD 126,415,269 on HIV-related activities as compared to USD 127,828,300 in 2021, a one per cent decrease in total expenditure in 2022. Out of the total expenditure, USD 51,650,765 was from the government, USD 20,589,629 from the private sector and USD 54,174,875 from international partners.

This is contained in the 2022 results of the National AIDS Spending Assessment (NASA) disseminated by Dr Kyeremeh Atuahene, Director General of the Ghana AIDS Commission in Accra on Wednesday.
He said the assessment showed that international organisations, primarily the global fund and the US government accounted for the treatment of the largest portion of financing with an increase of three per cent from 2021 to 2022.

NASA also indicated an increase of 19 per cent in the government’s expenditure towards HIV-related activities within the period.
Dr Atuahene said for HIV spending by programme areas, HIV treatment, care and support accounted for 53 per cent of HIV financing at an amount of USD
68,011,545.

He said the assessment also noted that areas such as social protection, development synergies and HIV-related research had received relatively little attention.
“The main beneficiary population was Person Living with HIV who received the highest proportion of funds thus 54 per cent on the total expenditure, followed by the general population, 6.2 per cent and 3.5 per cent for key populations.”

- Advertisement -

Dr Atuahene said for the year 2022, five HIV prevention pillars, thus Adult and Young People Living with HIV, key populations, condoms, Pre-exposure prophylaxis(PrEP) and Voluntary Medical Male Circumcision contributed to the greater part of the HIV prevention activities.

NASA is made yearly to track transactions related to public, private and foreign spending on HIV and AIDS across different sectors in support of the NSP2021-2025.
The assessment also facilitates country reporting to the United Nations General Assembly on Financing for
HIV and AIDS interventions in Ghana.

The Director General said NASA was more than a financial evaluation, saying, “It is a strategic tool that empowers us to assess the impact of interventions, identify areas for improvement and align efforts with the evolving needs of communities.”

Since 2005, Ghana has conducted and used NASA as its primary method for tracking HIV resources and the data has influenced HIV programmes.

Share This Article
Facebook Twitter Email Copy Link Print
Previous Article Mpox outbreak declared a public health emergency of international concern
Next Article RESETTING GHANA’S Healthcare syst; NDC’s Manifesto on Health
Leave a comment Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Ghana's NHIS Reaches 70% Universal Health Coverage, NHIA CEO, Dr Victor Asare Bampoe
Health News

Ghana’s NHIS Reaches 70% Universal Health Coverage

July 11, 2026
Ghana's NHIS Reaches 70% Universal Health Coverage, NHIA CEO, Dr Victor Asare Bampoe

Ghana’s NHIS Reaches 70% Universal Health Coverage

July 11, 2026

Webinar: Launch of New Guidelines on risk reduction of cognitive decline and dementia, second edition

July 11, 2026
Clinical Trials Ebola Dr Congo

WHO Launches Landmark Clinical Trial to Test First Potential Treatments for Bundibugyo Ebola in DR Congo

July 11, 2026

You Might Also Like

Ghana's NHIS Reaches 70% Universal Health Coverage, NHIA CEO, Dr Victor Asare Bampoe
Health News

Ghana’s NHIS Reaches 70% Universal Health Coverage

July 11, 2026
Health News

US CDC Raises Ebola Outbreak Response to Highest Level

July 1, 2026
Ebola WHO and Africa CDC
Health News

Africa CDC, WHO Launch US$518 Million Continental Plan to Combat Bundibugyo Ebola Outbreak

July 11, 2026
Discover & LearnGlobal

PCOS Renamed to PMOS in Major Global Move to Improve Women’s Health Diagnosis and Care

May 15, 2026

Ghana Health Nest

Your trusted source for health news, tips, and wellness resources in Ghana.

About

  • About Us
  • Contact Us
  • Advertise with us
  • Sitemap

Legal

  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
  • Editorial Policy

Follow us

Facebook Twitter Instagram Rss

©2026 Vessel Media. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?